CD47 and cancer: Exosomes from cancer cells show CD47 on their membranes.[121] Therefore, the engineered EM‐PLGA nanoparticles showed increased cancer‐targeting ability and decreased uptake by mononuclear phagocytes compared to lipid‐PLGA nanoparticles and CCM‐PLGA nanoparticles.